Article info
PDFOriginal research
Factors contributing to delays in initiation of front-line cervical cancer therapy: disparities in a diverse south Florida population
- Correspondence to Dr Marilyn Huang, Gynecologic Oncology, University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center, Miami, FL 33125, USA; m.huang{at}med.miami.edu
Citation
Factors contributing to delays in initiation of front-line cervical cancer therapy: disparities in a diverse south Florida population
Publication history
- Received March 10, 2022
- Accepted August 17, 2022
- First published October 5, 2022.
Online issue publication
November 07, 2022
Article Versions
- Previous version (5 October 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2022. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.